Every state, kept current
The Rates plan
$29/mo7-day free trialThis page shows one representative rate per state for M0249. Full schedules include every locality, modifier, and age-band variant.
- Every code on all 51 published schedules
- Full-schedule CSV export and state network lists
- Email alerts when a state changes its rates
$29/mo after the trial. Cancel anytime.
Publishing states
21
Median % of Medicare
--
Rate range
$235.61 - $571.95
M0249 rates in every publishing state
| State | Medicaid rate | % of Medicare | Prior auth | Vintage |
|---|---|---|---|---|
| Alaska | $571.95 | -- | -- | 2026 |
| Arkansas | $450.00 | -- | -- | 2026 |
| District of Columbia | $401.04 | -- | Not required | 2026 |
| Georgia | $360.00 | -- | -- | 2026 |
| Iowa | $459.62 | -- | -- | 2024 |
| Idaho | $432.00 | -- | Not required | 2025 |
| Indiana | $403.66 | -- | -- | 2021 |
| Kentucky | $450.00 | -- | -- | 2026 |
| Maryland | $450.00 | -- | -- | 2021 |
| Maine | $308.86 | -- | -- | 2026 |
| Michigan | $235.61 | -- | -- | 2026 |
| Missouri | $450.00 | -- | Not required | 2021 |
| Mississippi | $372.20 | -- | -- | 2023 |
| Montana | $450.00 | -- | -- | 2026 |
| North Dakota | $441.00 | -- | Not required | 2026 |
| New Hampshire | $450.00 | -- | Not required | 2026 |
| New Mexico | $455.67 | -- | -- | 2025 |
| Rhode Island | $542.72 | -- | -- | 2026 |
| Utah | $348.61* | -- | Not required | 2024 |
| Virginia | $450.00 | -- | -- | 2021 |
| Vermont | $427.50 | -- | -- | 2026 |
Published Medicaid fee-for-service schedule amounts, not a coverage or eligibility guarantee. Managed-care plan rates can differ. Where no prior-authorization flag is shown, the state does not publish one. Rows marked * are representative published variants or methodology-derived rates. "--" in the prior-auth column means the state publishes no PA flag.
Related state-specific services codes
- C1716 - Brachytherapy source, non-stranded, gold-198, per source
- C1717 - Brachytherapy source, non-stranded, high dose rate iridium-192, per source
- C1719 - Brachytherapy source, non-stranded, non-high dose rate iridium-192, per source
- C2616 - Brachytherapy source, non-stranded, yttrium-90, per source
- C2634 - Brachytherapy source, non-stranded, high activity, iodine-125, greater than 1.01 mci (nist), per source
- C2635 - Brachytherapy source, non-stranded, high activity, palladium-103, greater than 2.2 mci (nist), per source
- C2636 - Brachytherapy linear source, non-stranded, palladium-103, per 1 mm
- C2638 - Brachytherapy source, stranded, iodine-125, per source
All 4 codes from M0201 to M0250 or every state-specific services code by number.
Frequently asked questions
How much does Medicaid pay for M0249?
21 state Medicaid programs publish a fee-for-service rate for M0249 (intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, first dose), ranging from $235.61 in Michigan to $571.95 in Alaska. The full table on this page lists every publishing state's current rate.
Which state pays the most for M0249?
Alaska publishes the highest Medicaid rate for M0249 at $571.95. Michigan publishes the lowest at $235.61.
Does M0249 require prior authorization under Medicaid?
No publishing state flags M0249 with a prior-authorization indicator on its fee schedule. Absence of a flag means the state publishes none, not that PA is never required - confirm through the state's provider manual.